Problem
-
Newborn respiratory distress affects about 7% of all deliveries, primarily affecting premature infants due to their underdeveloped lungs.
-
Current non-invasive respiratory support systems such as continuous positive airway pressure (CPAP) and high flow nasal cannula (HFNC) do not deliver consistent pressures to the airway and provide no objective feedback of the pressure that is delivered.
-
Pressures that are too low or too high can result in serious health consequences, including secondary respiratory conditions (which may require rescue procedures) and/or other morbidities.
-
CPAP and HFNC failure rates remain unacceptably high (reported between 20-40%).
-
There remains no clear consensus on the optimal CPAP or HFNC level or how to most optimally wean an infant off respiratory support.
"We (clinicians) are essentially changing the pressures/flows blind, without knowing what is being delivered." - Neonatologist
At Ventora, we believe in empowering clinicians through innovation. We develop user-focused products which provide clinicians with the tools necessary to make informed clinical decisions and improve patient care."
- CEO, Edward Buijs
Ventora Airway Pressure Monitor
-
Aims to provide accurate, real-time monitoring of the mean airway pressure without added invasiveness
-
Measures pressure in the infant's airway, while competitor products measure pressures external to the patient
-
Dual-function device enables enteral feeding in addition to airway pressure monitoring
-
Intuitive and easy to use
-
Alarms to alert clinicians and nurses when under- and over-pressure events occur
-
Designed to support evidence-based, proactive respiratory treatment
"This device would allow us (clinicians) to titrate the respiratory treatment for a particular baby, at a particular time and for a particular stage and type of disease." - Neonatologist
Partners
Recent Updates
Ventora Medical's co-founders Amy Yu and Edward Buijs named on the
2021 Forbes 30 Under 30 Healthcare and Science List (Asia Pacific)
